Pure Global

Drug Eluting Coronary Stent System - India CDSCO Medical Device Registration

Drug Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000457_6a11d97158630de4cf3efb410f3c818b_d9d13f7f5965cf310dc1755be646fc8e. This device is marketed under the brand name BioFreedom. The license holder is Cartier Healthcare LLP, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Drug Eluting Coronary Stent System
UID: IMP/MD/2019/000457_6a11d97158630de4cf3efb410f3c818b_d9d13f7f5965cf310dc1755be646fc8e

Brand Name

BioFreedom

Device Class

Class D

Approving Authority

CDSCO

Product Information

The BioMatrix Alpha stent is indicated for improving coronary luminal diameter for the treatment of de novo lesions in native coronary arteries with a reference diameter ranging between 2.25mm and 4.0mm. Stents with lengths 33 and 36mm are only available for artery diameters ranging between 2.5 mm and 3.5 mm.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Other Products from Cartier Healthcare LLP
Products from the same license holder (2 products)